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ABSTRACT: Metal coordination complexes can display
interesting biological activity, as illustrated by the bleomycins
(BLMs), a family of natural antibiotics that when coordinated
to a redox-active metal ion, show antitumor activity. Yet,
which metal ion is required for the activity in cells is still
subject to debate. In this study, we described how diﬀerent
metal ions aﬀect the intracellular behavior and activity of the
synthetic BLM-mimic N,N-bis(2-pyridylmethyl)-N-bis(2-
pyridyl)methylamine (N4Py). Our study shows that a mixture
of iron(II), copper(II), and zinc(II) complexes can be generated when N4Py is added to cell cultures but that the metal ion can
also be exchanged by other metal ions present in cells. Moreover, the combination of chemical data, together with the
performed biological experiments, shows that the active complex causing oxidative damage to cells is the FeII-N4Py complex
and not per se the metal complex that was initially added to the cell culture medium. Finally, it is proposed that the high activity
observed upon the addition of the free N4Py ligand is the result of a combination of scavenging of biologically relevant metals
and oxidative damage caused by the iron(II) complex.
■ INTRODUCTION
Bleomycins (BLMs) are a family of natural antibiotics
produced by Streptomyces verticillus1 that are widely used as
chemotherapeutic drugs to treat various types of cancer.2
Coordination of a transition metal to its metal binding domain
(i.e., FeII or CuI) results in the formation of metallobleomycins,
which react with dioxygen under reductive conditions,3 causing
signiﬁcant oxidative damage to cellular organelles and
molecules.4−9
Extensive studies on BLMs in the past have indicated the
importance of identifying the role of diﬀerent metal species in
the overall working of the drug in vitro. In cell-free systems, the
activity of the metallobleomycins depends on the nature of the
coordinated metal.10−12 In these conditions, FeII-BLM shows
the highest DNA cleavage activity, whereas the addition of
excess CuII, ZnII, or CoII to BLM in the presence of FeII
completely abolishes its activity.12,13 In contrast, studies in cell
cultures show comparable levels of antitumor activity between
the diﬀerent metallobleomycins (ZnII, CuII, and FeII/III).14,15
The comparable antitumor activity of the diﬀerent metal-
lobleomycins may hint toward a common metallobleomycin
that is generated intracellularly by metal exchange.14,16
BLMs have inspired many ligands for the design of metal
polypyridyl complexes, of which the ligand N,N-bis(2-
pyridylmethyl)-N-bis(2-pyridyl)-methylamine (N4Py; Chart
1) has proven to be particularly successful.17 Since its
discovery, metal complexation of N4Py with FeII,17−19
MnII,20,21 CoII,22 NiII,23 CuII,24 ZnII,24,25 RuII,25−28 and PtII 29
has been reported.
We have been particularly interested in the biological activity
of N4Py. It has been shown in cell-free experiments that FeII-
N4Py complexes exhibit signiﬁcant DNA cleavage activity,
which has been postulated to involve the formation of N4Py-





36,37 and N4Py-MnIVO38,39 species have
been reported.
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Chart 1. Structure of the Ligand N4Py and the Metal
Complexes in the Solid State as Used in This Study
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Moreover, FeII-N4Py complexes exhibit high activity against
various cancer cell lines, albeit via a diﬀerent mechanism of
action than BLM. Whereas BLM induces double-stranded
DNA (dsDNA) breaks (DSBs) resulting in cell cycle arrest,
N4Py was shown to induce apoptotic cell death.40
Interestingly, it was shown in this and other studies that also
the free ligand exhibits biological activity. Jackson and
Kodanko showed that N4Py can eﬀectively bind and mobilize
FeII from ferritin in aqueous solution.41 Moreover, it was
shown that N4Py can chelate ZnII ions in cells, which was
proposed to result in inhibition of the X-linked inhibitor of
apoptosis protein (XIAP), resulting in cell death.42 This study
also suggested the ability of FeII-N4Py to generate ROS and
induce apoptotic cell death. Combined, these studies raise
questions about which metal complex is actually responsible
for the biological activity in cells, which is increasingly
recognized as an important aspect of the in vivo activity of
coordination complexes.43−50
Here, we demonstrate that metal-ion exchange in the
coordination of N4Py complexes is a very important aspect in
the biological activity of N4Py coordination complexes.
Particularly, we show that, irrespective of which metal ion
was bound to N4Py initially, it is the iron(II) complex that is
responsible for most of the observed activity. Our study
demonstrates unequivocally that the intracellularly active
complex does not necessarily correspond to the extracellularly
added metal complex.
■ RESULTS AND DISCUSSION
Metal Binding Studies. Iron(II), iron(III), manganese-
(II), copper(II), and zinc(II) complexes of N4Py were
synthesized following reported procedures (Supporting In-
formation).17,18,29,33,36,51 The complexes contain a molecule of
acetonitrile on the sixth coordination site, with the exception
of FeIII-N4Py, which contains a methoxy ion as the axial ligand
(L; Chart 1). The crystal structures from the diﬀerent metal-
N4Py complexes were compared (Figure S1 and Table S2),
and some clear structural trends can be discerned. First, the
average bond distances of the four equatorial M−NPy bonds
diﬀer quite signiﬁcantly, depending on the metal ion involved,
with the average M−NPy bond lengths for the manganese(II)
complex being 0.28 Å longer than those for the iron(II)
complex [2.251(8) Å over 1.971(8) Å, respectively]. The trend
in the average M−NPy bond lengths is manganese(II) >
zinc(II) > copper(II) ≈ iron(III) > iron(II). Second, the
position of the metal ion above the main plane of the four
equatorial nitrogen atoms diﬀers, with manganese(II) showing
the most distorted structure, being 0.55 Å out-of-plane, while
iron(II) shows the least distortion (0.21 Å).
The binding of N4Py to various metal ions in aqueous
solution has been studied, although this was done in various
conditions that are not necessarily representative for the
conditions of biological experiments. Hence, spectroscopic
characterizations of the various isolated complexes in solution
were performed under conditions relevant to the cell culture
studies (vide infra) as much as possible. The metal-N4Py
complexes (0.5 mM) were dissolved in phosphate-buﬀered
saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
1.8 mM KH2PO4, pH 7.4, 37 °C), and their UV/vis absorption
spectra and electrochemical properties were analyzed (Figure 1
and Table S3). All complexes showed pyridyl-centered ligand
π−π* charge-transfer transition bands between 200 and 300
nm. The absorption spectrum for MnII-N4Py showed an
additional weak shoulder around 320 nm (400 cm−1 M−1).
Cyclic voltammetry showed a MnIII/II irreversible oxidation at
Ep,a = 0.7 V vs Ag/AgCl.
20 The FeII-N4Py complex showed
two resolved absorption bands at 377 nm (2000 cm−1 M−1)
and 460 nm (1450 cm−1 M−1), assigned to metal-to-ligand
charge-transfer (1MLCT) transitions.19 An irreversible FeIII/II
redox process was observed at Epa = 0.18 V vs Ag/AgCl.
Correspondingly, the ferric complex showed a similar redox
wave and had a near-UV absorption band at 370 nm (>2500
cm−1 M−1).33 For CuII-N4Py, a broad absorption band
centered at 905 nm (170 cm−1 M−1) and a higher energy
shoulder around 730 nm (100 cm−1 M−1) were observed.
Cyclic voltammetry showed a reversible CuII/I redox wave at
Epa = −0.42 V vs Ag/AgCl, which is in accordance with
previous reports.37 The zinc-coordinated complex is spec-
troscopically silent. In its voltammogram, the irreversible
ligand redox wave at 1.02 V vs Ag/AgCl is absent,52,53 which
evidences binding of ZnII to N4Py. This conclusion is
supported by pronounced changes in the 1H NMR chemical
shifts of the ligand in comparison to N4Py alone (Supporting
Information).
Next, it was investigated whether N4Py was able to bind
these bioavailable metals in situ under cell-free conditions. The
spectra and voltammograms of the solutions containing 1:1
N4Py/metal ratios are shown in Figure 2.
The addition of aliquots of iron(II) salt to a N4Py solution
monitored by cyclic voltammetry showed the progressive
disappearance of the ligand oxidation wave and simultaneous
formation of the FeIII/II oxidation wave (Figure S2). Moreover,
the addition of FeII ions caused the almost immediate
formation of FeII-N4Py, as is evidenced by the typical
1MLCT bands in the UV/vis spectrum (Figure S3). On the
basis of the molar absorptivity determined for FeII-N4Py at 457
nm, a maximum conversion to the iron complex of 74% was
observed (Table S4). Contrary to the case with iron(II) salt,
the addition of iron(III) salt to N4Py did not result in the
formation of a charge-transfer band in the absorbance
spectrum, nor did it result in the disappearance of the ligand
oxidation wave or the formation of an FeII/III wave in the
voltammograms. The addition of MnII ions to N4Py resulted in
only the partial disappearance of the irreversible ligand
oxidation peak and the appearance of a broad peak
corresponding to the MnIII/II couple, suggesting that
Figure 1. UV/vis absorption spectra (top) and cyclic voltammograms
(bottom) of the metal-N4Py complexes (0.5 mM) in PBS (pH 7.4, 37
°C) under an argon atmosphere.
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coordination is not favored. The addition of CuII to N4Py
resulted in the complete disappearance of the ligand oxidation
wave and the appearance of the CuII/I redox wave. However,
formation of the broad absorption band around 900 nm (160
cm−1 M−1) showed a maximum conversion of 50% (Figure S3
and Table S4). The addition of ZnII to N4Py resulted in the
complete disappearance of the ligand oxidation peak,
suggesting that the ZnII-N4Py complex is readily formed. On
the basis of these results, it is evident that, under the indicated
conditions, N4Py coordinates readily to ZnII, CuII, and FeII,
while the coordination of MnII is not favored and almost no
coordination of FeIII is observed.
The possibility for exchange of FeII ions from the N4Py
complex with other biologically relevant metal ions was
investigated by treating the FeII-N4Py complex (0.5 mM)
with a variety of metal salts and monitoring the 1MLCT band
at 457 nm (Table 1 and Figure S4). During the time of the
measurement, no decrease of this band was observed upon the
addition of MnII, FeIII, or ZnII ions, suggesting that no metal
exchange occurs. In contrast, in the presence of CuII, a
decrease of the MLCT absorption band was observed, which
suggests that 70% of FeII-N4Py was converted to CuII-N4Py,
accompanied by the formation of the characteristic charge-
transfer absorption band and reversible redox peak of the
copper(II) complex (Figure S5).
Subsequently, the inverse experiment was performed to
study the ability of FeII to exchange with the diﬀerent metal
ions coordinated to N4Py, by following the formation of the
1MLCT band at 457 nm in time (Figures S6 and S7 and Table
1).
The addition of FeII ions to a solution of FeIII-N4Py resulted
in the fast and complete conversion to the iron(II) complex,
again suggesting the iron(II) complex is completely favored
over its iron(III) analogue. Note, however, that the conversion
is most likely the result of electron transfer, as opposed to the
actual physical exchange of metal ions. In the case of MnII-
N4Py, a majority of MnII is exchanged by FeII (57%), which
indicates that binding of MnII to N4Py is very labile, and the
addition of FeII ions leads to the rapid formation of a more
stable product. Signiﬁcant conversion of the copper(II)
complex is observed (39%), albeit with much slower kinetics
than that for manganese(II). Importantly, the conversion of
CuII-N4Py to form FeII-N4Py is faster than the reverse process.
This indicates that both FeII and CuII are quite inert in the
N4Py environment, with a slight kinetic preference for FeII-
N4Py. However, depending on the relative concentrations of
the metal ions, a mixture of both complexes will thus most
likely be present in cells. The zinc(II) complex is kinetically
quite stable under the indicated conditions: even though
almost half of the complex is converted to the iron(II) complex
(44%), consistent with the reported Kd values for the zinc(II)
and iron(II) complexes,42,54 the kinetics are slow. In summary,
FeII is thus capable of exchanging metal ions coordinated to
N4Py, and the ﬁnal degree of exchange is in the order MnII >
ZnII > CuII, a thermodynamic trend that is consistent with the
Irving−Williams series.55 Notably, the iron(II) complex itself
does not ﬁt in this trend; this is most likely because, at pH 7.4,
there are multiple iron(II) species present, of which at least
one is low spin and, hence, is kinetically more stable than the
related high-spin complexes.19
DNA Cleavage Experiments. As a measure for the
inherent catalytic activity, the DNA cleavage activities of the
diﬀerent metal-N4Py complexes were determined using
supercoiled pUC18 plasmid DNA at 37 °C in the presence
of dithiothreitol (DTT). Gel analysis after 30 min of
incubation showed almost the complete disappearance of
supercoiled DNA in the presence of FeII- and FeIII-N4Py, while
the other complexes did not show activity in DNA cleavage
(Figure 3a). The average number of single-strand cuts per
DNA molecule (n) was calculated from the amount of nicked
and linear DNA formed (Figure 3b; for equations, see the
Supporting Information). Clearly, the iron(II) and iron(III)
complexes caused the largest number of single-strand cuts (5.5
± 0.3 and 4.8 ± 0.3 cuts, respectively), with almost all
supercoiled DNA consumed within 30 min. Evidently, in the
cases of manganese(II), copper(II), and zinc(II), very little
cleavage activity was observed (<0.3 cuts), indicating their
almost negligible activity in cell-free systems.
Cell Studies. The biological activity of the metal-N4Py
complexes was evaluated by MTS assay.56,57 Two cancer cell
lines (A2780 and SKOV3) and a noncancerous cell line (OSE-
C2) were used in this study. Cells were treated for 24 h with
diﬀerent concentrations of N4Py and its metal complexes. The
IC50 values for all cell lines were found to be in the range of 5−
Figure 2. UV/vis absorption spectra (top) and cyclic voltammograms
(bottom) after the stoichiometric addition of metal perchlorate salts
to the N4Py ligand (0.5 mM) in PBS (pH 7.4, 37 °C) under an argon
atmosphere.
Table 1. Metal-Ion Exchange in N4Py Coordination
Complexes




















aConversion of FeII-N4Py to the N4Py complexes of the indicated
metal ions. bConversions at t = 1500 s, at which time the absorption
spectra had stabilized, suggesting that equilibrium is reached, unless
noted otherwise. c[N4Py] = 0.5 mM, [metal ion] = 0.5 mM, PBS
buﬀer, pH 7.4. dConversion of the indicated N4Py complexes to FeII-
N4Py upon the addition of an iron(II) metal salt. e[metal-N4Py] =
0.5 mM, [FeII] = 0.5 mM, PBS buﬀer, pH 7.4. fBecause of slow
exchange, the equilibrium had not yet been established at this time.
Inorganic Chemistry Article
DOI: 10.1021/acs.inorgchem.8b00714
Inorg. Chem. 2018, 57, 7748−7756
7750
10 μM for N4Py, MnII-N4Py, FeII-N4Py, and FeIII-N4Py
(Figure 4). Notably, an unusual sudden transition from high to
almost no cell viability was observed for these compounds
within this concentration range. This observation was in
agreement with the cell viability, as assessed by light
microscopy. The IC50 values for Cu
II-N4Py were around 50
μM, and treatment with ZnII-N4Py resulted in hardly any
decrease of the metabolic activity (IC50 > 50 μM).
The MTS assay can suﬀer from interfering processes.58−64
Moreover, because the decrease in the metabolic activity can
be explained by either cytotoxic or cytostatic processes, a
propidium iodide (PI)/ﬂuorescence-activated cell sorting
(FACS) assay was performed. Cells will only stain PI positive
once the cell membrane becomes permeable, i.e., when cells
are late apoptotic or necrotic. The PI assay was performed by
treating cells for 24 h with 10 μM of the metal complexes
(Figure 5) because this was the lowest concentration where
there were clear diﬀerences between the activities of diﬀerent
metal complexes (Figure 4). The CuII- and ZnII-N4Py
complexes showed the lowest cytotoxicity (5−10%), which
correlates with their minor eﬀect on the metabolic activity.
Conversely, MnII-, FeII-, and FeIII-N4Py showed signiﬁcant
amounts of cell death, ranging from 56% to 96%. Interestingly,
N4Py, i.e., the free ligand, was found to be the most toxic
compound in all three cell lines, with cell death levels varying
from 79% (±1.8) in A2780 cells up to 96% (±0.5) in OSE-C2
cells. On the basis of the cell-free experiments, the cytotoxicity
is expected to be induced by a metal-N4Py complex and not by
the ligand alone. Therefore, this result suggests that the N4Py
ligand is able to bind metals in the cellular environment. The
combined data of Figures 4 and 5 clearly indicate that the
decrease in the metabolic activity is mainly the result of a
cytotoxic eﬀect.
In view of the proposed oxidative mechanism of DNA
cleavage in cell-free systems by FeII-N4Py and the reported oxo
species of the Mn-, Fe-, and Cu-N4Py complexes (vide supra),
it can be assumed that the cytotoxicity of the metal-N4Py
complexes is a result of excessive ROS formation in the cells. In
order to determine the intracellular formation of highly
reactive oxygen species (hROS) upon treatment of the
A2780 cells with the N4Py ligand and its metal complexes,
the hROS probe 3′-(p-aminophenyl)ﬂuorescein (APF) was
selected (Figure 6).65 Treatment of A2780 cells with N4Py
gives a 2-fold (2.1 ± 0.1) increase in the ﬂuorescence of APF
versus 0.1% dimethyl sulfoxide (DMSO) control. This suggests
that N4Py enters the cell and binds transition metal ions
intracellularly to form complexes able to generate hROS. ZnII-
N4Py did not give rise to detectable ROS formation, which is
in agreement with it being redox-inactive. Additionally, the
exchange of ZnII for FeII is slow (vide supra), suggesting that
little of the FeII-N4Py complex is actually formed in the cells.
In the presence of the other complexes, the amount of ROS
detected increased between 1.6- and 2.3-fold with respect to
DMSO.
Upon cotreatment with the antioxidant N-acetylcysteine
(NAC), which protects cells from oxidants both directly, as a
scavenger of free radicals, and indirectly, as a precursor for
glutathione (GSH),66−68 hROS production by cells treated
Figure 3. (a) Gel analysis of the cleavage of supercoiled DNA (form
I) to give nicked DNA (form II) and linear DNA (form III) in Tris-
HCl (pH 8.0) at 37 °C after 30 min (with the exception of lanes 1
and 2). Concentrations used: 1.0 μM complex, 0.1 μg μL−1 pUC18
plasmid DNA (300 μM in base pairs), and 1.0 mM DTT. (b) Average
number of single-strand cuts per DNA molecule (n). Error bars
represent the uncertainty limits of the data, based on a Monte Carlo
simulation, taking into account a standard deviation σ of 0.03 of the
individual DNA fractions. A correction factor of 1.31 was used to
compensate for the reduced ethidium bromide uptake capacity of
supercoiled DNA.31
Figure 4. Metabolic activity (MTS assay) of (a) A2780, (b) SKOV3,
and (c) OSE-C2 cell lines upon treatment with metal-N4Py
complexes. Cells were treated for 24 h with 1, 3, 10, 30, and 50
μM N4Py and metal-N4Py complexes. Experiments were conducted
three times. Within each treatment, each treatment was measured
three times. Data are presented as the mean ± SEM.
Figure 5. Cytotoxicity upon treatment with metal-N4Py complexes.
The cell death was determined in A2780, SKOV3, and OSE-C2 cells
treated for 24 h with 10 μM N4Py and its metal complexes
[manganese(II), iron(II), iron(III), copper(II), and zinc(II)]. Cells
were stained by PI, and the percentage of late apoptotic/necrotic cells
was analyzed by FACS. Data are presented as the mean ± SEM from
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with N4Py and all metal-N4Py complexes was completely
abolished, except with CuII-N4Py (Figure 6). Remarkably, the
amount of hROS detected was almost doubled from 1.9× to
3.3× versus 0.1% DMSO upon the cotreatment of CuII-N4Py
with NAC. This is most likely caused by the reduction of CuII
to CuI by NAC, which can then form a complex CuI-GSH that
can react with molecular oxygen to produce ROS (vide
infra).69
These results support an increase of the hROS levels in
A2780 cells upon treatment with N4Py and its metal
complexes. Thus, PI/FACS assay was repeated in the presence
of two types of antioxidants: NAC or L-ascorbic acid 2-
phosphate (AA2P)70,71 (Figures 7 and S8). The level of cell
death induced in the diﬀerent cell lines (A2780, SKOV3, and
OSE-C2) was comparable for each treatment. Interestingly, the
presence of NAC or AA2P does not seem to impact the
amount of cell death when cells are treated with N4Py or MnII-
N4Py. On the contrary, cotreatment with NAC completely
abolished the cell death induced by the Fe-N4Py complexes,
with a clear eﬀect of AA2P as well. Furthermore, the presence
of NAC in the CuII-N4Py-treated cells resulted in a strong
increase in cell death (up to 100% in A2780), indicating that
the reduction of CuII to CuI by NAC not only induces hROS
production by reaction with dioxygen but also, as a
consequence, induces high levels of cell death. Treatment
with AA2P had no eﬀect on ROS formation by CuII-N4Py.
Likewise, ZnII-N4Py-treated cells showed no signiﬁcant
response to cotreatment with either NAC or AA2P.
Next, the ability of the diﬀerent complexes in inducing
oxidative DNA damage in vitro was studied. The extent of DSB
formation was determined using ﬂow cytometric detection of
phosphorylated histone H2AX (γH2AX).72 The histone
protein H2AX forms a key component in DNA repair because
it becomes rapidly phosphorylated at serine 139 and
accumulates at emerging DSB sites.73,74 After 24 h of treatment
with 30 μM N4Py and its metal complexes, the percentage of
γH2AX positive cells was determined in SKOV3 cells (Figure
8). Interestingly, signiﬁcantly higher γH2AX levels compared
to the solvent controls were observed for all reagents (P <
0.001), which indicates that, at this concentration, nuclear
DNA damage is induced by treatment with N4Py and all of the
metal complexes. The iron(II) complex appears to produce
slightly more dsDNA damage compared to the other reagents
(P < 0.001 against MnII-, CuII-, and ZnII-N4Py; P < 0.01
against N4Py and FeIII-N4Py). The eﬃciency of metal-N4Py
and N4Py for DSB is observed as follows: FeII-N4Py > N4Py ≈
MnII-N4Py ≈ FeIII-N4Py > CuII-N4Py ≈ ZnII-N4Py.
DSBs can be caused by various factors. Some reagents create
DSBs directly, such as BLM and doxorubicin,72,74 while others
have an indirect eﬀect, e.g., by triggering apoptosis.75 To assess
the contribution of apoptosis in the induction of DSBs by
N4Py and the metal-N4Py complexes, SKOV3 cells were
treated with the broad range caspase inhibitor carbobenzoxy-
valyl-alanyl-aspartyl-[O-methyl]-ﬂuoromethyl-ketone (ZVAD-
Figure 6. hROS formation upon treatment with metal-N4Py
complexes. A2780 cells were treated for 24 h with the N4Py ligand,
its metal complexes, or solvent control. The dashed columns
represent the results obtained by cotreating with 5 μM of the
antioxidant precursor NAC. hROS formation was detected by the
ROS probe APF. Flow cytometric analysis of APF emission was used
to obtain the mean ﬂuorescent intensity (MFI) for each condition.
The MFI was normalized to solvent control (green). Every
experiment was carried out three times. Each bar shows the mean
± SEM: ***, P < 0.001; **, P < 0.01; *, P < 0.05.
Figure 7. Eﬀect of antioxidants (NAC and AA2P) on the metal-
N4Py-complex-induced cytotoxicity. Cell death was determined in
A2780 cells treated for 24 h with 10 μM N4Py and its metal
complexes [manganese(II), iron(II), iron(III), copper(II), and
zinc(II)]. Dashed and squared columns show cells cotreated with 5
μM NAC or 16 h pretreated and cotreated with 173 μM AA2P,
respectively. Cells were stained by PI, and the percentage of late
apoptotic/necrotic cells was analyzed by FACS. Data are presented as
the mean ± SEM from three independent experiments: ***, P <
0.001; **, P < 0.01; *, P < 0.05.
Figure 8. dsDNA damage (γH2AX) in nonapoptotic/early apoptotic
cells induced by the metal-N4Py complexes. SKOV3 cells were
treated for 24 h with 30 μM N4Py and its metal complexes. FACS
analysis of γH2AX was used in combination with PI (marker for DNA
content) to exclude late apoptotic cells (subG1 peak) from analysis.
Cotreatment with 20 μM of the pan-caspase inhibitor ZVAD-FMK
could reveal the contribution of apoptosis to the total DSB induction.
The gate for γH2AX positive cells in solvent control was set at 5%.
Each value represents the mean ± SEM from three independent
experiments: ***, P < 0.001; **, P < 0.01; ns, not signiﬁcant.
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FMK).76 Upon the addition of ZVAD-FMK, a large reduction
of 46−57% in the γH2AX levels was observed for all
compounds except for ZnII-N4Py, where a 20% reduction
was obtained (Figure 8). This suggests that about half of the
observed dsDNA damage is the result of apoptosis induced by
N4Py or metal complexes. Nevertheless, even after inhibition
of the caspase-dependent apoptosis pathway, the amount of
observed dsDNA damage was still signiﬁcant for all reagents (P
< 0.05 for CuII-N4Py and P < 0.001 for N4Py and MnII-, FeII-,
FeIII-, and ZnII-N4Py), suggesting that direct DNA damage is
induced by N4Py or that also other cell death mechanisms may
be involved.
Relationship between the Metal-Ion Coordination
and Biological Activity. In this study, we described how
diﬀerent metal ions aﬀect the intracellular properties of the
synthetic BLM-mimic N4Py. Combined, these ﬁndings give
rise to the following hypothesis (Scheme 1): we propose that
the main active complex that causes oxidative damage to the
cell is the FeII-N4Py complex, irrespective of the initial metal
ion coordinated. This is supported by the following arguments:
(i) The structural and binding studies show that, while most
of the common bioavailable metal ions bind to N4Py,
formation of the iron(II) complex is the most favorable and
exchange of the bound metal ion for FeII occurs, albeit that it
should be noted that the thermodynamically most stable
complex is not necessarily catalytically active.
(ii) In cell-free experiments, FeII-N4Py is the only complex
that showed oxidative DNA cleavage activity. In contrast,
intracellularly, DSBs were generated with all metal complexes,
albeit with diﬀerent eﬃciencies: the addition of FeII-N4Py gave
the highest number of DSBs, whereas CuII-N4Py and ZnII-
N4Py gave rise to the lowest number. It was shown that at least
part of these DSBs are directly generated by the metal-N4Py
complex itself, whereas the rest are generated indirectly, i.e., via
the induction of apoptosis. This is in line with our previous in
vitro observations for the FeII-N4Py complex.40
(iii) It is proposed that the observed oxidative damage, in
part, can be ascribed to direct oxidation by the Fe-N4Py
complex, which seems to be the only complex of N4Py that is
capable of oxidizing cellular components, such as DNA. Even
though formation of an N4Py-Cu−OOH species has been
reported,36 it was found to be a sluggish oxidant. Similarly,
many Mn-oxo complexes show much less reactivity in
oxidation reactions than their Fe-oxo counterparts.77 Because
coordination of MnII to N4Py does not appear to be favorable
and MnII is readily exchanged for FeII, it is likely that mainly
metal exchange, forming the FeII-N4Py complex, is responsible
for the observed intracellular activity. In addition, ZnII is not
redox-active.78
(iv) Both iron(II) and iron(III) complexes are very active in
the cleavage of supercoiled pUC18 plasmid DNA. The
similarity in the cleavage activity is expected because the
presence of a large excess of DTT will force the ferric complex
into a ferrous complex. Similarly, the reducing conditions in
the cell will convert the iron(III) complex into the iron(II)
complex and, therefore, essentially give the same biologically
active complex involving an oxidative mechanism of action.79,80
The cytotoxicity of all metal-N4Py complexes in living cells can
therefore principally be ascribed to the FeII-N4Py complex.
Some apparent contradictions in the presented data further
support our hypothesis:
(i) The high kinetic stability of the ZnII-N4Py complex is
likely to account for its low cytotoxicity in the cell. Exchange
with the more favored FeII ion is possible, albeit limited by the
slow exchange rate. In line with this, no hROS formation was
observed upon treatment with ZnII-N4Py. The slight increase
in DSBs may be accounted for by the slow exchange with FeII
in the N4Py complex.
(ii) CuII-N4Py seems to be the most preferred complex
under physiological conditions, as a signiﬁcant, albeit minor,
species. The lack of pUC18 plasmid DNA cleavage activity
suggests the low oxidizing power of the copper(II) complex.
Generally, the cell studies with CuII-N4Py resulted in little
cytotoxicity to the cells at low concentrations, supporting that
the copper(II) complex is the most prevalent complex even
though the presence of iron(II) can result in formation of the
FeII-N4Py complex. This suggests that the elevated concen-
trations of copper following the addition of the copper
complex, rather than the physiological copper concentration,
contribute to the favored formation of the copper complex.81,82
(iii) The high cytotoxicity and related high hROS levels
detected for CuII-N4Py in the presence of NAC seem to be a
direct result of CuII interaction and complex formation with
GSH to form CuI-(GSH)2, resulting in strongly elevated ROS
levels.69,83−85 This result is in agreement with the reported
interaction of BLM with CuII in the presence of a reducing
agent.86−89
Interestingly, the cellular damage induced by treatment of
the free ligand N4Py is even higher than that obtained with the
corresponding metal complexes. We propose that this can be
ascribed by the combination of two eﬀects:
(i) Intracellular chelation of the diﬀerent metals contributes
to the cytotoxicity observed for N4Py. From the binding
competition experiments and the association/dissociation
constants for the diﬀerent metals as found in the literature, it
can be deduced that the N4Py ligand may act as a ZnII,42 CuII,
and FeII chelator.41 Therefore, by chelating, and, thus,
scavenging metals, N4Py can inﬂuence many diﬀerent cellular
processes. For example, Zuo et al. have shown that ZnII
chelation by N4Py is associated with inhibition of the
XIAP.42 By chelating ZnII, N4Py may induce apoptosis. In
Scheme 1. Overview of the Coordination Chemistry of
N4Py in Tumor Cells
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another case, N4Py was shown to successfully mobilize iron
from ferritin (in 5 h, 5% of the total iron from ferritin is
liberated),41 the main intracellular iron storage protein.90 This
is in contrast to BLM, for which it was shown that it is unable
to exchange metals with the iron storage proteins transferrin
and ferritin.87
(ii) Additionally, the iron(II) complex of N4Py that is
formed then is causing oxidative damage to the cells, as
described above. Therefore, we propose that the increased
cytotoxicity of the N4Py ligand compared to the FeII-N4Py
complex can be ascribed to the additive eﬀect of the
intracellular chelation of metals, as well as oxidative damage.
However, this study does not fully take into account the
possible diﬀerences in the cellular inﬂux of the diﬀerent
compounds, which can have an hitherto unknown inﬂuence on
the ﬁnal concentrations in the cells.
■ CONCLUSION
In this study, it was investigated how the coordination of
diﬀerent ﬁrst-row transition-metal ions could inﬂuence the
activity of the N4Py ligand in cultured cells. The results of our
study indicate that a mixture of iron(II), copper(II), and
zinc(II) complexes can be generated when N4Py is added to
cell cultures. However, the combination of chemical data from
analysis of the metal-N4Py complexes by UV/vis and cyclic
voltammetry, together with the performed biological experi-
ments, strongly suggests that the active complex that causes the
oxidative damage to cells is the FeII-N4Py complex and not per
se the metal complex that was initially added to the cell culture
medium; that is, metal-ion exchange has to be considered in
the analysis of the biological data.
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